Next |
home / stock / pdsb / pdsb message board
Subject | By | Source | When |
---|---|---|---|
PDSB excellent setup for next leg up... Very | l2 hunter | investorshub | 01/10/2023 2:36:31 PM |
Lol crypto not looking there right now too | starkd748 | investorshub | 01/04/2023 2:02:57 PM |
Need to look again...I haven't looked so nice | starkd748 | investorshub | 01/03/2023 9:23:42 PM |
Thoughts on efxusdt? Looks like inverse head and | Lwrnc2052 | investorshub | 01/03/2023 7:23:39 PM |
Got your pm ...Stochastic 90s on the weekly | starkd748 | investorshub | 01/03/2023 3:14:52 PM |
Maybe...The weekly stochastic is over 90 though same | starkd748 | investorshub | 12/30/2022 8:00:38 AM |
Can it run more?? https://ycharts.com/companies/$PDSB/news .. 12/28 ..PDS Biote | tw0122 | investorshub | 12/30/2022 2:00:54 AM |
Biotech mover | starkd748 | investorshub | 12/29/2022 9:52:10 PM |
znewcar1: $PDSB 23% v2,7M c11.40 f28,5M H11.48 ML7.95 | znewcar1 | investorshangout | 12/28/2022 9:39:29 PM |
Back in play | starkd748 | investorshub | 12/01/2022 6:11:47 PM |
overbought on the stochastic too many lower lows | starkd748 | investorshub | 11/29/2022 3:17:38 PM |
Just hot a intraday head n shoulders....consolidation | starkd748 | investorshub | 11/18/2022 4:55:03 PM |
Not on a Friday | starkd748 | investorshub | 11/18/2022 3:54:17 PM |
Gonna hit the 10's today | Bertsllc | investorshub | 11/18/2022 1:40:44 PM |
weeeeeeeeee weeeeeeeeeeeee | starkd748 | investorshub | 11/17/2022 6:23:38 PM |
Weeeeeeee | starkd748 | investorshub | 11/17/2022 4:32:19 PM |
Yup very explosive | starkd748 | investorshub | 11/15/2022 11:27:33 PM |
Weeee clear to 11s | starkd748 | investorshub | 11/15/2022 3:16:27 PM |
$PDSB Update: | MiamiGent | investorshub | 11/14/2022 4:49:58 PM |
$PDSB PDS BIOTECHNOLOGY CORP | MiamiGent | investorshub | 11/14/2022 3:58:00 PM |
News, Short Squeeze, Breakout and More Instantly...
PDS Biotechnology Corporation Company Name:
PDSB Stock Symbol:
NYSE Market:
PDS Biotechnology Corporation Website:
Company to Host Key Opinion Leader Event on May 8 at 1:30pm ET to Discuss Updated Results of VERSATILE-002, Unmet Treatment Needs in Advanced Head and Neck Cancer and planned Triple Combination Trial PRINCETON, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq...
Unique mechanism of action of the combination of PDS01ADC and Versamune ® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to focus late-stage clinical strategy on triple combination of PDS01ADC,...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...